(Q87595272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

An approach to evaluating and comparing biomarkers for patient treatment selection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Margaret Sullivan Pepe

4

object named as

Margaret S Pepe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Holly Janes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Marshall D Brown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Ying Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Biostatistics

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

99-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods

12 March 2020

cites work

1 reference

12 December 2020

Analysis of randomized comparative clinical trial data for personalized treatment selections

1 reference

12 December 2020

Testing for improvement in prediction model performance.

1 reference

12 December 2020

Assessing treatment-selection markers using a potential outcomes framework

1 reference

12 December 2020

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

1 reference

12 December 2020

A review of goodness of fit statistics for use in the development of logistic regression models

1 reference

12 December 2020

PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

1 reference

12 December 2020

Subgroup identification from randomized clinical trial data

1 reference

12 December 2020

Semiparametric methods for evaluating the covariate-specific predictiveness of continuous markers in matched case-control studies

1 reference

12 December 2020

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX

1 reference

12 December 2020

Variable selection for optimal treatment decision

1 reference

12 December 2020

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

1 reference

12 December 2020

One statistical test is sufficient for assessing new predictive markers

1 reference

12 December 2020

EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY.

1 reference

12 December 2020

Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer

1 reference

12 December 2020

Misuse of DeLong test to compare AUCs for nested models

1 reference

12 December 2020

Interaction between prognostic factors and treatment.

1 reference

12 December 2020

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

12 December 2020

A framework for evaluating markers used to select patient treatment

1 reference

12 December 2020

Patterns of treatment effects in subsets of patients in clinical trials

1 reference

12 December 2020

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

12 December 2020

Testing for qualitative interactions between treatment effects and patient subsets.

1 reference

12 December 2020

A robust method for estimating optimal treatment regimes

1 reference

12 December 2020

A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials

1 reference

12 December 2020

Variable selection for qualitative interactions in personalized medicine while controlling the family-wise error rate

1 reference

12 December 2020

Comparing ROC curves derived from regression models

1 reference

12 December 2020

International Web-based consultation on priorities for translational breast cancer research

1 reference

12 December 2020

A generalized estimator of the attributable benefit of an optimal treatment regime

1 reference

12 December 2020

Evaluating the incremental value of new biomarkers with integrated discrimination improvement

1 reference

12 December 2020

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

1 reference

12 December 2020

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

12 December 2020

Measuring the performance of markers for guiding treatment decisions

1 reference

12 December 2020

Evaluating the predictiveness of a continuous marker

1 reference

12 December 2020

Measures to summarize and compare the predictive capacity of markers.

1 reference

12 December 2020

Method for evaluating prediction models that apply the results of randomized trials to individual patients

1 reference

12 December 2020

Evaluating markers for selecting a patient's treatment

1 reference

12 December 2020

Lost in translation: problems and pitfalls in translating laboratory observations to clinical utility

1 reference

12 December 2020

Identifiers

DOI

10.1515/IJB-2012-0052

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24695044%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

PubMed publication ID

24695044

1 reference